This is a "connection" page, showing publications co-authored by Joshua Rhett and Christina Grek.
Connection Strength

  1. Connexin 43, breast cancer tumor suppressor: Missed connections? Cancer Lett. 2016 Apr 28; 374(1):117-126.
    View in: PubMed
    Score: 0.139
  2. Targeting connexin 43 with a-connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1. BMC Cancer. 2015 Apr 03; 15:296.
    View in: PubMed
    Score: 0.131
  3. Cardiac to cancer: connecting connexins to clinical opportunity. FEBS Lett. 2014 Apr 17; 588(8):1349-64.
    View in: PubMed
    Score: 0.122
  4. The connexin 43 carboxyl terminal mimetic peptide aCT1 prompts differentiation of a collagen scar matrix in humans resembling unwounded skin. FASEB J. 2021 08; 35(8):e21762.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.